2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …
campaigns have helped to raise awareness about the impact of cardiovascular disease in …
Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation
P Osmancik, D Herman, P Neuzil, P Hala… - Journal of the American …, 2020 - jacc.org
Background Percutaneous left atrial appendage closure (LAAC) is noninferior to vitamin K
antagonists (VKAs) for preventing atrial fibrillation (AF)–related stroke. However, direct oral …
antagonists (VKAs) for preventing atrial fibrillation (AF)–related stroke. However, direct oral …
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion–an update
M Glikson, R Wolff, G Hindricks, J Mandrola… - EP …, 2020 - academic.oup.com
This article has been co-published with permission in EP Europace and EuroIntervention. All
rights reserved. VC 2019 the European Heart Rhythm Association and the European …
rights reserved. VC 2019 the European Heart Rhythm Association and the European …
5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials
VY Reddy, SK Doshi, S Kar, DN Gibson… - Journal of the American …, 2017 - jacc.org
Abstract Background: The PROTECT AF (WATCHMAN Left Atrial Appendage System for
Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that left atrial …
Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that left atrial …
[HTML][HTML] Фибрилляция и трепетание предсердий. Клинические рекомендации 2020
МГ Аракелян, ЛА Бокерия, ЕЮ Васильева… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …
[HTML][HTML] 2020 Clinical guidelines for Atrial fibrillation and atrial flutter
MG Arakelyan, LA Bockeria… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …
2018 joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or …
In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …
[HTML][HTML] Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up …
LV Boersma, H Ince, S Kische, E Pokushalov… - Heart rhythm, 2017 - Elsevier
Background Left atrial appendage (LAA) occlusion with WATCHMAN has emerged as viable
alternative to vitamin K antagonists in randomized controlled trials. Objective EWOLUTION …
alternative to vitamin K antagonists in randomized controlled trials. Objective EWOLUTION …
Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation
L Fauchier, A Cinaud, F Brigadeau, A Lepillier… - Journal of the American …, 2018 - jacc.org
Background: Transcatheter left atrial appendage (LAA) occlusion is an alternative strategy
for stroke prevention in patients with atrial fibrillation (AF). Objectives: This study sought to …
for stroke prevention in patients with atrial fibrillation (AF). Objectives: This study sought to …